Drug intelligence / Profile preview

Teosyal PureSense Redensity 1

Development stage
Unknown
Lead developer
Teoxane
Modality
Small Molecules
Administration
Intradermal
01

Overview

Teosyal PureSense Redensity 1 is a non-crosslinked hyaluronic acid-based skinbooster developed by Teoxane. It is an injectable gel designed to improve skin quality by restoring hydration, increasing skin density, and enhancing radiance in areas such as the face, neck, décolleté, and hands. The formulation contains 15 mg/ml of non-crosslinked hyaluronic acid, 0.3% lidocaine hydrochloride for local anesthesia, and a proprietary Dermo-Restructuring Complex (DRC). The DRC includes 14 essential nutrients: eight amino acids (glycine, lysine, threonine, proline, isoleucine, leucine, valine, and arginine), three antioxidants (glutathione, N-acetyl-L-cysteine, and alpha-lipoic acid), two minerals (zinc and copper), and vitamin B6. The product works by physically replenishing the dermal matrix and providing essential nutrients to stimulate fibroblast activity, promoting the production of collagen and elastin while offering antioxidant protection against premature skin aging.

Brand names
Teosyal PureSense Redensity 1Teosyal Redensity 1
Other names
Teosyal Redensity IRedensity 1Redensity1Redensity-1
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Teosyal PureSense Redensity 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teosyal PureSense Redensity 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call